Update: 03.12.2024
Last week: 47 week 2024 (18.11.2024 - 24.11.2024)
Last full month: October 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 148 | -9.4% | 13.3% | -0.1 | 18 233 225 | -7.1% | 9.0% | 0 | -8.4% |
| MoM | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| YTD | 374 903 | 22.8% | 12.2% | 3.1 | 750 635 835 | 29.2% | 9.3% | 1.7 | -8.8% |
| MAT | 410 521 | 22.6% | 12.0% | 2.9 | 826 330 844 | 30.2% | 9.2% | 1.6 | -7.4% |
| BRAINMAX | |||||||||
| WoW | 2 588 | -18.2% | 100.0% | 0 | 8 677 061 | -16.6% | 100.0% | 0 | -18.2% |
| MoM | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| YTD | 70 960 | 75.8% | 100.0% | 0 | 246 843 829 | 78.2% | 100.0% | 0 | 75.8% |
| MAT | 77 237 | 77.8% | 100.0% | 0 | 269 310 112 | 81.5% | 100.0% | 0 | 77.8% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 055 | -10.6% | 46.2% | -1.9 | 43 753 202 | -10.3% | 37.2% | -1.8 | -6.9% |
| MoM | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| YTD | 760 521 | -4.8% | 45.3% | 0.5 | 2 386 865 540 | -3.1% | 37.1% | -2.6 | -5.8% |
| MAT | 831 005 | -3.6% | 45.4% | 0.6 | 2 614 955 212 | -1.3% | 37.3% | -2.4 | -4.9% |
| MIGRENIUM | |||||||||
| WoW | 8 793 | -15.4% | 0.4% | -0.1 | 2 989 982 | -15.8% | 0.5% | -0.1 | -2.7% |
| MoM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| YTD | 525 370 | -10.9% | 0.5% | -0.1 | 166 873 367 | 50.6% | 0.7% | 0.2 | 5.7% |
| MAT | 577 141 | -12.8% | 0.5% | -0.1 | 178 753 064 | 44.6% | 0.6% | 0.1 | 7.3% |
| MODELAX-N | |||||||||
| WoW | 26 869 | -6.2% | 19.9% | -1 | 13 200 267 | -7.3% | 13.2% | -0.9 | -1.6% |
| MoM | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| YTD | 1 329 456 | 25.8% | 22.0% | 3.1 | 591 380 684 | 73.3% | 14.3% | 3.8 | 7.9% |
| MAT | 1 440 594 | 27.1% | 21.5% | 3 | 632 900 393 | 72.5% | 13.8% | 3.5 | 9.4% |
| REDUXIN | |||||||||
| WoW | 9 954 | -0.4% | 32.7% | 2.1 | 53 166 725 | -1.5% | 45.2% | 2.1 | -6.9% |
| MoM | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| YTD | 549 216 | -7.0% | 32.7% | -0.4 | 2 914 922 090 | 10.9% | 45.3% | 2.9 | -5.8% |
| MAT | 596 808 | -6.5% | 32.6% | -0.5 | 3 160 507 625 | 12.2% | 45.0% | 2.8 | -4.9% |
| REDUXIN FORTE | |||||||||
| WoW | 2 816 | -13.2% | 9.2% | -0.7 | 12 191 085 | -11.7% | 10.4% | -0.7 | -6.9% |
| MoM | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| YTD | 153 344 | 0.8% | 9.1% | 0.6 | 659 340 628 | 11.2% | 10.2% | 0.7 | -5.8% |
| MAT | 167 229 | 1.3% | 9.1% | 0.6 | 720 027 308 | 12.1% | 10.3% | 0.6 | -4.9% |
| SALVISAR | |||||||||
| WoW | 14 860 | -9.0% | 2.0% | -0.1 | 6 602 485 | -9.1% | 1.8% | -0.1 | -4.3% |
| MoM | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
| YTD | 506 239 | 11.1% | 1.4% | 0.2 | 211 344 151 | 41.2% | 1.3% | 0.2 | -3.1% |
| MAT | 549 116 | 4.7% | 1.4% | 0.1 | 225 433 028 | 29.7% | 1.3% | 0.1 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 374 903 | 22.8% | 12.2% | 3.1 | 750 635 835 | 29.2% | 9.3% | 1.7 | -8.8% |
| BRAINMAX | 70 960 | 75.8% | 100.0% | 0 | 246 843 829 | 78.2% | 100.0% | 0 | 75.8% |
| GOLDLINE PLUS | 760 521 | -4.8% | 45.3% | 0.5 | 2 386 865 540 | -3.1% | 37.1% | -2.6 | -5.8% |
| MIGRENIUM | 525 370 | -10.9% | 0.5% | -0.1 | 166 873 367 | 50.6% | 0.7% | 0.2 | 5.7% |
| MODELAX-N | 1 329 456 | 25.8% | 22.0% | 3.1 | 591 380 684 | 73.3% | 14.3% | 3.8 | 7.9% |
| REDUXIN CAPS | 549 216 | -7.0% | 32.7% | -0.4 | 2 914 922 090 | 10.9% | 45.3% | 2.9 | -5.8% |
| REDUXIN FORTE | 153 344 | 0.8% | 9.1% | 0.6 | 659 340 628 | 11.2% | 10.2% | 0.7 | -5.8% |
| SALVISAR | 506 239 | 11.1% | 1.4% | 0.2 | 211 344 151 | 41.2% | 1.3% | 0.2 | -3.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 410 521 | 22.6% | 12.0% | 2.9 | 826 330 844 | 30.2% | 9.2% | 1.6 | -7.4% |
| BRAINMAX | 77 237 | 77.8% | 100.0% | 0 | 269 310 112 | 81.5% | 100.0% | 0 | 77.8% |
| GOLDLINE PLUS | 831 005 | -3.6% | 45.4% | 0.6 | 2 614 955 212 | -1.3% | 37.3% | -2.4 | -4.9% |
| MIGRENIUM | 577 141 | -12.8% | 0.5% | -0.1 | 178 753 064 | 44.6% | 0.6% | 0.1 | 7.3% |
| MODELAX-N | 1 440 594 | 27.1% | 21.5% | 3 | 632 900 393 | 72.5% | 13.8% | 3.5 | 9.4% |
| REDUXIN CAPS | 596 808 | -6.5% | 32.6% | -0.5 | 3 160 507 625 | 12.2% | 45.0% | 2.8 | -4.9% |
| REDUXIN FORTE | 167 229 | 1.3% | 9.1% | 0.6 | 720 027 308 | 12.1% | 10.3% | 0.6 | -4.9% |
| SALVISAR | 549 116 | 4.7% | 1.4% | 0.1 | 225 433 028 | 29.7% | 1.3% | 0.1 | -1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 148 | -9.4% | 13.3% | -0.1 | 18 233 225 | -7.1% | 9.0% | 0 | -8.4% |
| BRAINMAX | 2 588 | -18.2% | 100.0% | 0 | 8 677 061 | -16.6% | 100.0% | 0 | -18.2% |
| GOLDLINE PLUS | 14 055 | -10.6% | 46.2% | -1.9 | 43 753 202 | -10.3% | 37.2% | -1.8 | -6.9% |
| MIGRENIUM | 8 793 | -15.4% | 0.4% | -0.1 | 2 989 982 | -15.8% | 0.5% | -0.1 | -2.7% |
| MODELAX-N | 26 869 | -6.2% | 19.9% | -1 | 13 200 267 | -7.3% | 13.2% | -0.9 | -1.6% |
| REDUXIN CAPS | 9 954 | -0.4% | 32.7% | 2.1 | 53 166 725 | -1.5% | 45.2% | 2.1 | -6.9% |
| REDUXIN FORTE | 2 816 | -13.2% | 9.2% | -0.7 | 12 191 085 | -11.7% | 10.4% | -0.7 | -6.9% |
| SALVISAR | 14 860 | -9.0% | 2.0% | -0.1 | 6 602 485 | -9.1% | 1.8% | -0.1 | -4.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| BRAINMAX | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| GOLDLINE PLUS | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| MIGRENIUM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| MODELAX-N | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| REDUXIN CAPS | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| REDUXIN FORTE | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| SALVISAR | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs